1Gottlieb SS, MeCarter R J, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction [ J ]. N Engl J Med, 1998,339 ( 8 ) :489 - 497.
2Padeletti M,Jelic S, Lejemtel TH. Coexistent chronic obstructive pulmonary disease and heart failure in the elderly [ J ]. lnt J Cardiol,2008,125 (2) :209 -215.
3Salpeter SR,Ormiston TM,Salpeter EE, et al. Cardioselective betablockers for chronic obstructive puhnonary disease : a meta-analysis [ J ]. Respir Med, 2003,97 ( 10 ) : 1094 - 1101.
4Jemtel TH,PadelettiM,Jelic S. Diagnostic and therapeutic challenges in patientswith coexistent chronic obstructive pulmonary disease and chronic heart failure [ J ]. J Am Coll Cardiol, 2007,49 ( 2 ) : 171 - 180.
6Chen J, Radford M J, Wang Y, et al. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma [ J ]. J Am Coil Cardiol,2001,37(7 ) :1950 - 1956.
7Au DH, Bryson CL, Fan VS, et al. Beta-blockers as single-agenl therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease [ J ]. Am J Med,2004, 117(12) :925 -931.
8Ovcharenko Sl,Litvinova IV, Mikolkin VI. Administralion of cardioselective beta-adrenoblockcrs in patients with arterial hypertension and/or ischemic heart disease associated with bronchoobstractive syndrome [ J ]. Ter Arkh,2007,79 (9) : 12 - 1 8.
9Van Gestel YR, Hocks SE, Sin DD, et al. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis [ J ]. Am J Respir Crit Care Med ,2008,178:695 -700.
10van Gestel YR, Hoeks SE, Sin DD, et al. Beta-blockers and healthrelated quality of life in patients with peripheral arterial disease and COPD [ J ]. lnt J Chron Obstruct Pulmon Dis, 2009,4 : 177 - 183.
3Jabbour A, Macdonald PS, Keogh AM, et al. Differences betweenbeta-blockers in patients with chronic heart failure and chronic ob- structive pulmonary disease:a randomized crossover trial [ J ]. J Am Coll Cardiol, 2010,55 ( 17 ) : 1780 - 1787.
4Dorow P, Tonnesmann U. Dose-response relationship of the ]3-adre- noceptor antagonists bisoprolol in the patients with coronary heart disease and chronic obstructive bronchitis[ J ]. Eur J Clin Pharma- col, 1984,27 : 135 - 139.
